Acquisitions20 Jun 2026, 05:30 pm
Sun Pharma Acquires 100% of Innovcare Lifesciences for ₹271.2 Cr
AI Summary
Sun Pharmaceutical Industries Limited has announced the acquisition of 100% outstanding shares of Innovcare Lifesciences Private Limited for a cash consideration of approximately ₹271.2 Crores. Innovcare Lifesciences is engaged in the marketing, distribution, and sale of pharmaceutical drugs, nutraceutical, and cosmeceutical products. The acquisition is a strategic investment aimed at strengthening Sun Pharma's product portfolio. The deal is expected to be completed by July 31, 2026. Innovcare reported revenues of INR 94.06 crores for FY 2025-26.
Key Highlights
- Sun Pharma to acquire 100% of Innovcare Lifesciences.
- Acquisition cost is approximately ₹271.2 Crores in cash.
- Strategic move to enhance Sun Pharma's product portfolio.
- Innovcare Lifesciences operates in pharma, nutraceutical, and cosmeceutical sectors.
- Deal expected to close by July 31, 2026.
Price Impact
More from SUNPHARMA